Singapore markets closed

Verona Pharma plc (VRNA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
15.47+0.16 (+1.05%)
At close: 04:00PM EDT
15.47 0.00 (0.00%)
After hours: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
458
40,000
0
Cost of revenue
0
0
346
0
-
Gross profit
0
0
112
40,000
-
Operating expenses
Research development
17,216
17,216
49,283
79,406
44,505
Selling general and administrative
50,353
50,353
26,579
33,907
29,772
Total operating expenses
66,465
66,465
66,228
97,683
66,010
Operating income or loss
-66,465
-66,465
-66,116
-57,683
-66,010
Interest expense
2,057
2,057
521
340
35
Total other income/expenses net
1,866
1,866
-4,632
2,422
924
Income before tax
-53,895
-53,895
-68,448
-55,587
-65,000
Income tax expense
474
474
253
-18
146
Income from continuing operations
-54,369
-54,369
-68,701
-55,569
-65,146
Net income
-54,369
-54,369
-68,701
-55,569
-65,146
Net income available to common shareholders
-54,369
-54,369
-68,701
-55,569
-65,146
Basic EPS
-0.56
-0.72
-1.04
-0.96
-2.00
Diluted EPS
-0.56
-0.72
-1.04
-0.96
-2.00
Basic average shares
78,105
79,268
66,134
59,149
32,867
Diluted average shares
78,105
79,268
66,134
59,149
32,867